Advisory Committee Conflict Of Interest Policy More Flexible In Final Form
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA releases slew of committee-related guidances, including draft on the criteria to determine when a committee meeting should be held.
You may also be interested in...
FDA Resolves Ovation Sabril Conflict Of Interest; Sets Jan. 7-8 Advisory Panel Meeting
Peripheral and CNS Drugs Advisory Committee to consider two indications for Sabril: to treat infantile spasms and as adjunctive therapy for refractory complex partial seizures in adults.
FDA Resolves Ovation Sabril Conflict Of Interest; Sets Jan. 7-8 Advisory Panel Meeting
Peripheral and CNS Drugs Advisory Committee to consider two indications for Sabril: to treat infantile spasms and as adjunctive therapy for refractory complex partial seizures in adults.
FDA Changes Advisory Committee Voting Procedure To Ensure Integrity Of Vote Results
FDA advisory committee members would vote simultaneously rather than sequentially on issues before the panel to avoid influencing each others' votes, according to draft guidance.